NCT06009926 2026-03-19
Evaluation of Broccoli Seed and Sprout Extract for Detoxification of Carcinogens in Firefighters
National Cancer Institute (NCI)
Phase 2 Active not recruiting
Clinical Trials
12 trialsNCT02439034 2026-03-16
KETOCOL
Centre Oscar Lambret
Phase 2 Completed
NCT06043323 2026-03-12
A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT05896228 2026-03-11
Iber-KDd
University of Miami
Phase 2 Recruiting
NCT06788912 2026-03-10
MK-3475-01E
Merck Sharp & Dohme LLC
Phase 2 Recruiting
NCT03913559 2026-02-12
Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia
St. Jude Children's Research Hospital
Phase 2 Terminated
NCT01391962 2026-02-02
Sunitinib or Cediranib for Alveolar Soft Part Sarcoma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT05704049 2025-12-29
IZALCO
Sanofi
Phase 2 Active not recruiting
NCT05842044 2025-09-05
No-PAIN
University of Miami
Phase 2 Recruiting
NCT00712712 2025-08-29
MEDOR
Institut Bergonié
Phase 2 Completed
NCT04165096 2025-06-25
MK-3475-01C
Merck Sharp & Dohme LLC
Phase 2 Completed
NCT01059786 2025-06-12
Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia
National Institutes of Health Clinical Center (CC)
Phase 2 Active not recruiting